Lawrence Blonde
27PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (27)
Sort by Publication Date:
|Jul 15, 2022
A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes.Vanita R Aroda, Lawrence Blonde, Richard E Pratley
|Jun 16, 2021
Efficacy of liraglutide added to sodium-glucose cotransporter-2 inhibitors in type 2 diabetes, stratified by baseline characteristics: Post-hoc analysis of LIRA-ADD2SGLT2i.Lawrence Blonde, Udi Fainberg, Margit S Kaltoft
|Jun 10, 2021
Improving Management of Type 2 Diabetes Using Home-Based Telemonitoring: Cohort Study.Richard Milani, Pavan Chava, Jonathan Wilt
|Apr 21, 2021
Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world: A review of the DELIVER programme.Lawrence Blonde, Timothy Bailey, Sean D Sullivan
|Feb 10, 2021
Switching to iGlarLixi versus continuation of a daily or weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) in insufficiently controlled type 2 diabetes: A LixiLan-G trial subgroup analysis by HbA1c and GLP-1 RA use at screening.Julio Rosenstock, Lawrence Blonde, Vanita R Aroda
|Jan 20, 2021
Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study.Lawrence Blonde, Julio Rosenstock, Juan Frias
Pageof 5
Frequent Collaborators
6 joint publications
Julio Rosenstock
6 joint publications
Vanita R Aroda
4 joint publications
Fang Liz Zhou
4 joint publications
Stefano Del Prato
4 joint publications
Juan Pablo Frias
3 joint publications
Philip Home
2 joint publications
Steven Kahn
2 joint publications
Linda DiMeglio
2 joint publications
George Bakris
2 joint publications
Matthew C Riddle
